213 related articles for article (PubMed ID: 22699850)
1. Evolutional aspects of Alzheimer's disease pathogenesis.
Braak H; Del Tredici K
J Alzheimers Dis; 2013; 33 Suppl 1():S155-61. PubMed ID: 22699850
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease: pathogenesis and prevention.
Braak H; Del Tredici K
Alzheimers Dement; 2012 May; 8(3):227-33. PubMed ID: 22465174
[TBL] [Abstract][Full Text] [Related]
3. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.
Braak H; Del Tredici K
Brain; 2015 Oct; 138(Pt 10):2814-33. PubMed ID: 26283673
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
Takeda M; Kudo T; Taniguchi N; Nishimura T
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
[No Abstract] [Full Text] [Related]
5. Alzheimer's disease. Tangle disentanglement.
Beyreuther K; Masters CL
Nature; 1996 Oct; 383(6600):476-7. PubMed ID: 8849716
[No Abstract] [Full Text] [Related]
6. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
7. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Goedert M
Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?].
Braak H; Feldengut S; Del Tredici K
Nervenarzt; 2013 Apr; 84(4):477-82. PubMed ID: 23508204
[TBL] [Abstract][Full Text] [Related]
11. Where, when, and in what form does sporadic Alzheimer's disease begin?
Braak H; Del Tredici K
Curr Opin Neurol; 2012 Dec; 25(6):708-14. PubMed ID: 23160422
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
[TBL] [Abstract][Full Text] [Related]
13. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
14. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Goedert M; Spillantini MG; Hasegawa M; Jakes R; Crowther RA; Klug A
Cold Spring Harb Symp Quant Biol; 1996; 61():565-73. PubMed ID: 9246483
[No Abstract] [Full Text] [Related]
15. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW; Lee VM; Trojanowski JQ
Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
[TBL] [Abstract][Full Text] [Related]
17. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
18. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta, tau, and dementia.
Takashima A
J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
[TBL] [Abstract][Full Text] [Related]
20. Truncated tau protein as a new marker for Alzheimer's disease.
Novák M
Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
